RLAY

NASDAQ HEALTHCARE

Relay Therapeutics Inc

$18.06

-$0.58 (-3.11%)

Live quote

52w: $3.03 – $20.79

Loading chart…

P/E Ratio—

P/B Ratio5.56

EV/EBITDA—

Debt/Equity—

ROE-43.05%

ROIC—

Revenue Growth53.44%

Gross Margin—

Relay Therapeutics, Inc. is a clinical-stage precision drug company. The company is headquartered in Cambridge, Massachusetts.

Create a free account to add RLAY to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.